Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.USPTO Allows MDRNA’s Patent Application
The US Patent and Trademark Office (USPTO) has allowed patent application US 11/627,863 to MDRNA. It covers methods for the delivery of a broad array of compounds with
The US Patent and Trademark Office (USPTO) has allowed patent application US 11/627,863 to MDRNA. It covers methods for the delivery of a broad array of compounds with
Scynexis has achieved a third milestone in its collaboration with Merck & Co to develop antifungal agents. The latest milestone payment was triggered following the initiation of clinical
Amcor has received European Commission (EC) approval to proceed with the acquisition of the Alcan Packaging, that Amcor is purchasing from Rio Tinto. A condition of this approval
Arrayit Diagnostics, a majority-owned subsidiary of Arrayit Corporation, has reported its anticipated timeline for commercialisation of its microarray-based OvaDx pre-symptomatic ovarian cancer blood test. It is currently advancing
Abaxis has entered into the production animal diagnostics marketplace with its first product, a rapid Avian influenza antigen test. This is a USDA-licensed test for Avian influenza type
Mettler Toledo has presented roller compaction process optimisation using at-line particle characterisation, during the 2009 AAPS Annual Meeting, where the application of in situ particle characterisation was demonstrated
Inverness Medical has presented the study published in Intensive Care Medicine, carried out in Vicenza, Italy. The study tested blood samples collected during admission to the ICU using
Mettler Toledo (Mettler) has reported that it was approached by a major gelatin capsule manufacturer to optimise its capsule counting system. The company was selected by its customer’s
Durect has presented positive results from a 60 patient Phase IIb clinical trial of Posidur, a proprietary product under development for the treatment of post-surgical pain. Top line
The US Patent and Trademark Office (USPTO) has issued a Notice of Allowance for LifeCycle Pharma’s (LCP) patent application directed to its fenofibrate tablet. The patent application covers